Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Example: quiz answers
Public Assessment Report Decentralised Procedure …
PAR Equasym XL 40 mg, 50 mg and 60 mg modified-release capsules, hard UK/H/0819/004-6/DC 1 Public Assessment Report Decentralised Procedure EQUASYM XL 40 MG MODIFIED-RELEASE CAPSULES, HARD EQUASYM XL 50 MG MODIFIED-RELEASE CAPSULES, HARD EQUASYM XL 60 MG MODIFIED-RELEASE CAPSULES, HARD (Methylphenidate hydrochloride) Procedure No: UK/H/0819/004- 6/DC UK Licence No: PL 27303/0007-9 SHIRE PHARMACEUTICALS IRELAND LIMITED PAR Equasym XL 40 mg, 50 mg and 60 mg modified-release capsules, hard UK/H/0819/004-6/DC 2 LAY SUMMARY This is a summary of the Public Assessment Report (PAR) for Equasym XL 40 mg, 50 mg and 60 mg modified-release capsules, hard. These products will be referred to as Equasym XL in the remainder of this summary. This summary explains how Equasym XL w as assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use Equasym XL.
PAR Equasym XL 40 mg, 50 mg and 60 mg modified-release capsules, hard UK/H/0819/004-6/DC 1. Public Assessment Report . Decentralised Procedure
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: